A daughter of bradykinin that protects against septicaemia.
S A Doggrell
Index: Expert Opin. Investig. Drugs 10(8) , 1567-9, (2001)
Full Text: HTML
Abstract
When the defence response of the body to infectious bacteria fails, septic shock ensues with hypotension and death. RPPGF,(1-5)-bradykinin, was until recently considered to be an active metabolite of bradykinin. In an animal model of septicaemia (lipopolysaccharide administration to rats), RPPGF is protective, and can even prolong life. RPPGF, or stable mimetics, have potential in the treatment of septic shock.
Related Compounds
Related Articles:
2004-10-01
[Clin. Pharmacol. Ther. 76(4) , 379-87, (2004)]
Thrombostatin inhibits cyclic flow variations in stenosed canine coronary arteries.
2001-11-01
[Thromb. Haemost. 86(5) , 1296-304, (2001)]
Thrombostatin FM compounds: direct thrombin inhibitors - mechanism of action in vitro and in vivo.
2008-05-01
[J. Thromb. Haemost. 6(5) , 837-45, (2008)]
Bradykinin metabolism in rat hind limbs.
1998-08-01
[Shock 10(2) , 146-52, (1998)]
Oral thrombostatin FM19 inhibits prostate cancer.
2010-11-01
[Thromb. Haemost. 104(5) , 1044-8, (2010)]